Emmaus Life Science, the biotech lab confronting Sickle Cell Disease, has raised a $1.7M Venture round, looking to improve research on the debilitating disease.
Page 2 of 5
Emmaus Life Science, the biotech lab confronting Sickle Cell Disease, has raised a $1.7M Venture round, looking to improve research on the debilitating disease.
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.